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Objective. Ovarian cancer is the most lethal gynecological malignancy. Prevention may be the best ap-
proach to reduce ovarian cancer. Flaxseed is the richest vegetable source of omega-3 fatty acids which may
be effective in the prevention of ovarian cancer. Prostaglandin E2 (PGE2) is the most pro-inﬂammatory
ecoisanoid and one of the downstream products of two isoforms of cyclooxygenase (COX) enzymes: COX-1
and COX-2. Our objective was to determine if long-term consumption of a ﬂaxseed enriched diet decreased
ovarian cancer severity and incidence in the laying hen and to investigate its potential correlation with the
expression of COX enzymes and PGE2 concentration.
Methods. White Leghorn hens were fed 10% ﬂaxseed-enriched or standard diet for 4 years. The severity
and incidence of ovarian cancer were determined by gross pathology and histology. COX-1 and COX-2 pro-
tein and mRNA expression and PGE2 concentrations in ovaries were measured by Western blot, quantitative
real-time PCR and ELISA, respectively.Results. The results demonstrated that there was a reduction in ovarian cancer severity and incidence in
hens fed ﬂaxseed diet. In correlation with decreased ovarian cancer severity and incidence, concentration of
PGE2 and expression of COX-2 were diminished in ovaries of hens fed ﬂaxseed.
Conclusions. Our ﬁndings suggest that the lower levels of COX-2 and PGE2 are the main contributing fac-
tors in the chemo-suppressive role of long-term ﬂaxseed consumption in ovarian cancer in laying hens. These
ﬁndings may provide the basis for clinical trials of dietary intervention targeting prostaglandin biosynthesis
for the prevention and treatment of ovarian cancer.© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Prevention of ovarian cancer is the best approach for reducing
the impact of this deadly disease. Progress in the treatment andauthors declare that there are
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nc. Open access under CC BY-NC-ND licenseprevention of ovarian cancer has been hampered due to the lack of a
valid and appropriate animal model, and absence of effective chemo-
prevention strategies. Promising ﬁndings come from studies with
the laying hen, a robust model of spontaneous ovarian cancer that re-
capitulates the human disease. Dietary intervention with ﬂaxseed, the
richest vegetable source of omega-3 fatty acids (OM-3FAs) and phyto-
estrogen lignans, demonstrate the potential for effective prevention
and amelioration of ovarian cancer by targeting inﬂammatory prosta-
glandin pathways.
Cyclooxygenase (COX) is the rate limiting enzyme in catalyzing
the conversion of arachidonic acid (AA) to prostaglandin H2. Speciﬁc
prostaglandin synthases act on PGH2 to produce prostaglandins and
thromboxanes. Two identiﬁed isoforms of cyclooxygenase are: COX-1
and COX-2 which have similar structure and function, but encoded.
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patterns. Both COX enzymes may be involved in tumor establishment
[1] and maintenance of existing tumors [2]. Up-regulation of COX-2
has been reported in many malignancies, however, we and others
have shown that COX-1 is over-expressed in ovarian cancer [2–4]. Pros-
taglandins (PGs) are downstream products of cyclooxygenase enzymes
and PGE2 is commonly elevated in different human cancers including
colon, lung, breast, and head and neck cancers [5].
Dietary intervention with ﬂaxseed to prevent cancer was ﬁrst pro-
posed by Budwig in the 1950s [6]. OM-3FA consumption has been
associated with the prevention of many cancers. Inhibitory effects
of ﬂaxseed on prostate [7], intestine and colon cancer [8] have been
reported. The most well understood mechanism for the chemo-
preventive action of OM-3FAs is their suppressive effect on the pro-
duction of arachidonic acid-derived prostanoids, particularly PGE2 [9].
Flaxseed is the richest plant sources of the OM-3FA alpha-linolenic
acid (ALA, C18:3 ω-3). ALA is elongated to form eicosapentaenoic acid
(EPA, C20:5ω-3) and docosahexaenoic (DHA, C20:6ω-3) acid in the in-
testine. Alongwith theOM-3FAs, theﬂaxseed lignan secoisolariciresinol
diglucoside (SDG) ismetabolized in the digestive tract to phytoestrogens
enterodiol (END) and enterolactone (ENL), which are potent anti-
estrogens. In addition to the potential anti-cancer actions of ﬂaxseed
via estrogen antagonism, the lignan metabolites are also potent anti-
oxidants with the ability to inhibit lipid peroxidation and DNA scis-
sion, and scavenge hydroxyl radicals [10].
Ovarian cancer is the ﬁfth leading cause of cancer death among
women and remains as the most lethal gynecological malignancy.
Regardless of the origin of ovarian cancer, there is evidence to suggest
that womenwith fewer numbers of ovulations during their reproduc-
tive life are less prone to develop ovarian cancer. While the role that
ovulation might play is controversial, it is evident that ovulation is
important to the initiation of the disease [11]. Multiparity, duration
of lactation and use of birth control pills all decrease the risk of epi-
thelial ovarian cancer [12]. The domestic hens ovulate almost daily
and spontaneously develop ovarian adenocarcinomas that are similar
in histological appearance to human ovarian carcinomas and share
similar symptoms of the disease, such as perfuse ascites ﬂuid and
peritoneal metastatic dissemination [13,14].
We reported that old laying hens which were fed a ﬂaxseed
enriched diet for one year experienced a signiﬁcant decrease in the se-
verity of ovarian cancer and increased survival. The long-term efﬁcacy
of dietary intervention with ﬂaxseed on ovarian cancer incidence, and
the mechanisms through which ﬂaxseed works is unclear. The aims of
this study were 1) to determine if long term consumption (>4 years)
of a ﬂaxseed enriched diet decreases ovarian cancer incidence as well
as severity; and 2) to investigate the correlation between ovarian COX
enzyme expression, PGE2 tissue concentrations, ﬂaxseed consumption
and cancer incidence in old laying hens. The results of this study
demonstrate that long term consumption of ﬂaxseed decreases the
incidence and severity of ovarian cancer in hens. Moreover, COX-2 ex-
pression, but not COX-1, and PGE2 levels in the ovaries were signiﬁ-
cantly reduced by ﬂaxseed consumption. The results suggest that
ﬂaxseed targets the prostaglandin pathway to prevent and treat this
highly lethal malignancy.
Material and methods
Animals
1200 single comb white Leghorn hens, aged 6 months, were ran-
domly divided into two groups (n = 600). The ﬁrst group was fed
control diet and second group was fed 10% ﬂaxseed enriched diet.
The composition of the diets has been shown previously [15]. A per-
centage of both corn and soy were removed from the experimental
diet to keep the diets isocaloric with the addition of the ﬂaxseed. The
hens were fed 110 grams of feed a day and were provided water adlibitum. Hens on the ﬂaxseed diet consumed around 11 grams of ﬂax-
seed per day, or 6.2 g/kg body weight. Hens were maintained three
per cage and exposed to a photoperiod of 17 h light: 7 h dark, with
lights on at 05:00 h and lights off at 22:00 h. Animal management
and procedures were reviewed and approved by the Institutional
Animal Care and Use Committees at the University of Illinois at
Urbana-Champaign, University of Illinois at Chicago and Southern
Illinois University at Carbondale.
Collection of tissue
At the age of 12, 19, 24, 31, 36 and 45 months, twenty hens from
each of control and ﬂaxseed group were randomly selected, eutha-
nized using CO2 asphyxation and necropsied. Samples from chickens
aged 19, 31 and 45 months were designated as 1.5, 2.5 and 3.5 years
old, respectively. The ovarian tissues were processed as previously
described [16].
Histology
Ovarian tissues ﬁxed in NBF were processed and parafﬁn embed-
ded as previously described [3,14,17]. Four micrometer sections
were cut and mounted on SuperFrost Plus microscope slides. Slides
were deparafﬁnized and rehydrated through xylene and graded etha-
nol solutions. Hematoxylin and eosin staining were performed as de-
scribed [18].
RNA extraction and analysis and quantitative real-time PCR
Total RNA was extracted from ovarian tissue using Trizol reagent.
The quantiﬁcation and the quality check was performed as previously
described [16]. RNA samples were treatedwith RQ1 RNase-free DNase
prior to reverse transcription reaction. cDNA was synthesized from
DNase treated RNA with the high capacity cDNA archive kit. The
chicken-speciﬁc primers and plasmid standards used for each gene
were designed and qRT-PCR was conducted as previously shown [16].
Western blot
The proteins were extracted from snap frozen ovarian tissue sam-
ples and the western blot was performed to detect COX-1 and COX-2
as described previously [16].
PGE2 EIA
The amount of PGE2 in ovarian tissues from hens in both control
and ﬂaxseed fed groups was measured using a speciﬁc enzyme im-
munoassay as shown previously [16].
Statistical analysis
All experiments were performed in duplicate at each time-point
(n = 20) and differences in data from groups were analyzed with
GraphPad InStat by using One-way ANOVA with Student–Newman–
Keuls. Dichotomous data were analyzed using the Chi Square test in
GraphPad InStat. Outcome differences with a pr A value of P b 0.05
was considered signiﬁcant whereas a value of P b 0.01 was consid-
ered highly signiﬁcant.
Results
Flaxseed decreased the incidence of ovarian cancer
Upon necropsy of 20 hens from each group at each time-point, ova-
ries were classiﬁed as normal, cancerous or suspected abnormalities.
Ovaries with suspected abnormalities were analyzed by histology to
622 E. Eilati et al. / Gynecologic Oncology 130 (2013) 620–628conﬁrm the cancerous ovarian tissue (Fig. 1A-F). Tumors from both
control diet and ﬂaxseed enriched diet groups were analyzed and
characterized according to previously published tumor classiﬁcation
method [15]. Fig. 1G presents the percentage of hens with ovarian
cancer. No malignancy was detected in ovaries of hens fed a ﬂaxseed
enriched diet and hens fed control diet aged 1, 1.5 and 2 years; how-
ever, 6 month later, 10% of 2.5 year old chickens fed control diet
(n = 2) had ovarian cancer whereas 5% of hens fed a ﬂaxseed diet
had ovarian cancer (n = 1). Sixty ﬁve percent of 3 year old hens fedA
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Fig. 1. (A) Gross anatomy of normal ovary with a hierarchy of developing follicles; (B) Ovary
cancer; (D) H&E stain of normal ovary with developing small follicles; (E) H&E stain of suspe
and formation of focal lesions in the stroma below the ovarian surface was apparent (arrow
slit-like sheets containing cells with high-grade nuclear atypia and a few tiny glands were a
incidence in hens fed ﬂaxseed enriched and control diet. Necropsy of hens was performe
or questionable. Questionable ovarian tissues were analyzed by histology to conﬁrm the
(n = 0/20) and 2 (n = 0/20) year old hens in both ﬂaxseed and control groups; however
(n = 1/20) of hens fed ﬂaxseed had ovarian cancer. There was a difference in ovarian ca
hens fed a ﬂaxseed enriched diet aged the same (n = 9/20) (45%), but it was not statistically
in 3.5 year old hens compared to hens fed control diet (P b 0.05). (H) Comparison of early
control diet. The cancerous ovary of 2.5 year old hen fed a ﬂaxseed enriched diet was at th
the same on control diet. At the age of 3 year old, 8 early stage and only 1 late stage ovarian
were observed in 3 year old hens on control diet but there was more late stage ovarian cance
fed a ﬂaxseed enriched diet but interestingly, all of 10 ovarian cancers detected in 3.5 yearcontrol diet (n = 13) had ovarian cancer but ﬂaxseed enriched diet,
reduced the prevalence of ovarian cancer to 45% in the hens of the
same age (n = 9), however, the difference was not statistically signif-
icant (P > 0.05). Only 20% of 3.5 year old fed a ﬂaxseed enriched diet
(n = 4) had ovarian cancer whereas ﬁfty percent of 3.5 year old hens
fed control diet (n = 10) had ovarian cancer indicating that ﬂaxseed
signiﬁcantly reduced the incidence of ovarian cancer in 3.5 year old
hens (P b 0.05). Hens fed ﬂaxseed had less late stage tumors indica-
tive of the chemosuppressive actions of ﬂaxseed (Fig. 1H). In contrast,C
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classiﬁed as a suspected; (C) Ovary taken from a hen with metastatic late stage ovarian
cted ovary showed a disassociated stoma with unusually high numbers of blood vessels
); (F) H&E stain of metastatic late stage ovarian cancer with solid areas composed of
lso seen without any papillae. Calibration Bar, 20 μm (G) Percentage of ovarian cancer
d at different time-points (n = 20) and ovaries were classiﬁed as normal, cancerous
cancerous ovarian tissue. No ovarian malignancy was detected in 1 (n = 0/20), 1.5
, 10% of 2.5 year old (n = 2/20) hens fed control diet had ovarian cancer whereas 5%
ncer incidence in 3 years old hens fed control diet (n = 13/20) (65%) compared to
signiﬁcant. Flaxseed enriched diet signiﬁcantly reduced the incidence of ovarian cancer
and late stage ovarian cancer between hens fed a ﬂaxseed enriched diet and hens fed
e late stage but one early and one late stage ovarian cancer were found in hens aged
cancer were detected in hens fed ﬂaxseed diet; similarly, 8 early stage ovarian cancer
r (n = 5). One early and 3 late stage ovarian cancer were observed in 3.5 year old hens
old hens fed control diet were at the late stage. *, P b 0.05.
623E. Eilati et al. / Gynecologic Oncology 130 (2013) 620–628hens on the control diet had more late stage tumors (T3/T4) that
presented with ascites ﬂuid and metastasis compared to the ﬂaxseed
group.
Effect of ﬂaxseed on COX-1expression
No signiﬁcant differences were detected when the expression of
COX-1 protein and mRNA in normal ovaries of hens fed a ﬂaxseed
enriched diet at each time-point compared to COX-1 protein and
mRNA expression in normal ovaries of hens fed control diet aged
the same (P > 0.05; Fig. 2). There was no difference in expression
of COX-1 protein and mRNA between cancerous ovaries of hens fed
a ﬂaxseed enriched diet and cancerous ovaries hens fed control diet
at each time-point (P > 0.05; Fig. 3).
Effect of ﬂaxseed on COX-2 expression
There were no signiﬁcant differences in COX-2 protein and mRNA
expression in normal ovaries of 1, 1.5 and 2 year old hens fed a ﬂax-
seed enriched diet compared to normal ovaries of 1, 1.5 and 2 year
old hens fed control diet, respectively (P > 0.05; Fig. 4 A and B).
Normal ovaries of 2.5 (n = 19), 3 (n = 11) and 3.5 (n = 16) year
old hens fed a ﬂaxseed enriched diet had signiﬁcantly lower expres-
sion of COX-2 protein compared to normal ovaries of 2.5 (n = 18), 3
(n = 7) and 3.5 (n = 10) year old hens fed control diet, respectively
(Fig. 4A and B). Similar to the protein expression, normal ovaries of 2.5
(n = 19), 3 (n = 11) and 3.5 (n = 16) year old hens fed a ﬂaxseed
enriched diet had lower COX-2mRNA expression compared to normal
ovaries of hens fed control diet aged the same (P b 0.05; Fig. 4 C).
A signiﬁcant difference in COX-2 protein and mRNA expression
was found between cancerous ovaries of 3 year old hens fed a ﬂax-
seed enriched diet (n = 9) versus cancerous ovaries of hens fed con-
trol diet aged the same (n = 13; P b 0.05; Fig. 5). The 3.5 year old
chickens fed a ﬂaxseed enriched diet (n = 4) had lower COX-2 pro-
tein and mRNA expression in their cancerous ovaries compared to
the cancerous ovaries of 3.5 year old hens fed control diet (n = 10;
P b 0.05; Fig. 5).0
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Fig. 2. Expression of COX-1 protein and mRNA was measured in normal ovaries of hens f
6 month intervals. (A& B) No signiﬁcant differences in COX-1 protein expression in norma
ages (P > 0.05). (C) Similar to the protein expression, ﬂaxseed diet did not change the COX
diet (P > 0.05). Bars indicate standard error.Flaxseed decreases PGE2 concentrations in ovaries
PGE2 concentrations were measured in ovaries of hens as a possi-
ble function of ﬂaxseed enriched diet. Signiﬁcantly lower amounts of
PGE2 were found in normal ovaries of 1 (n = 8), 1.5 (n = 8) and 2
(n = 8) year old hens fed a ﬂaxseed enriched diet compared to nor-
mal ovaries of 1 (n = 8), 1.5 (n = 8) and 2 (n = 8) year old hens
fed control diet, respectively (P b 0.05; Fig. 6A). The normal ovaries
of 2.5 year old hens fed a ﬂaxseed enriched diet (n = 8) had signiﬁ-
cantly lower PGE2 concentrations compared to normal ovaries of
2.5 year old hens fed control diet (n = 8; P b 0.01). Furthermore,
ﬂaxseed enriched diet decreased the PGE2 concentrations in normal
ovaries of 3 (n = 8) and 3.5 (n = 8) year old hens compared to nor-
mal ovaries of 3 (n = 7) and 3.5 (n = 8) year old hens fed control
diet, respectively (P b 0.001).
The concentrations of PGE2 in cancerous ovaries of 3 (n = 8) and
3.5 (n = 4) year old hens fed a ﬂaxseed enriched diet were decreased
compared to cancerous ovaries of age matched hens fed control diet
(n = 8) (P b 0.001; Fig. 6B).
Discussion
The goals of our study were to investigate the effect of long term
consumption of ﬂaxseed enriched diet on the incidence and severity
of ovarian cancer and to compare the expression of COX-1, COX-2
and concentration of PGE2 in normal and cancerous hen ovaries to
determine any potential correlation. Here, we report that long-term
consumption of 10% ﬂaxseed enriched diet decreases the incidence
and severity of ovarian cancer in the laying hen. The expression of
both COX-2 protein and mRNA was decreased in normal ovaries of
2.5, 3 and 3.5 year old hens fed a ﬂaxseed enriched diet compared
to normal ovaries of age-matched hens on control diet. Flaxseed
down-regulated the COX-2 protein and mRNA expression in cancer-
ous ovaries of 3 and 3.5 year old hens compared to cancerous ovaries
of 3 and 3.5 hens fed control diet, respectively. At all ages, normal ova-
ries of hens fed a ﬂaxseed enriched diet had lower PGE2 concentra-
tions compared to normal ovaries of hens fed control diet indicating    2                   2.5          2.5                 3                3                  3.5               3.5
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Fig. 3. Expression of COX-1 protein and mRNA was measured in cancerous ovaries of hens fed a ﬂaxseed enriched diet and cancerous ovaries of hens fed control diet at approxi-
mately 6 month intervals. There was no signiﬁcant difference in COX-1 protein (A&B) and mRNA (C) expression in cancerous ovaries of 3 and 3.5 year old hens fed a ﬂaxseed
enriched diet versus age matched hens fed control diet (P > 0.05). Bars indicate standard error.
624 E. Eilati et al. / Gynecologic Oncology 130 (2013) 620–628a negative correlation between ﬂaxseed consumption and PGE2 con-
centrations in the ovaries. In correlation with decreased incidence
and severity of ovarian cancer, concentration of PGE2 was decreased
signiﬁcantly in cancerous ovaries of 3.5 year old hens fed ﬂaxseed
compared to cancerous ovaries of hens on control diet at the same age.
Cancer appears in hens starting at 2–2.5 years of age [16]. We
have shown that when hens of this age are fed a ﬂaxseed enriched
diet for one year, there was a signiﬁcant amelioration of ovarian
cancer, markedly reducing the severity of the disease in affected
hens [15]. The overall wellbeing of the ﬂaxseed-fed hens was also
improved by several criteria including a signiﬁcant reduction in mor-
tality. However, the overall incidence of cancer was not reduced inthe ﬂaxseed-fed hens compared to age-matched control diet-fed hens.
It is likely that the older hens had already experienced signiﬁcant
ovulation induced inﬂammatory damage to their ovaries and were
harboring occult disease. The anti-inﬂammatory actions of the ﬂaxseed
enriched diet reduced the progression of the disease so that at time of
necropsy the affected hens presented withmuch less advanced disease.
The present study was conducted so that hens would be provided
ﬂaxseed diet from the time of their ﬁrst lay (around 6 months of age)
for 4 years, until they reached the age of the old hens used in the ﬁrst
study. The results of the present study demonstrate that there was
a signiﬁcant reduction in the incidence of ovarian cancer, as well as a
reduction in the severity of ovarian cancer in the few hens which did
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Fig. 4. Expression of COX-2 protein and mRNA was measured in normal ovaries of hens in both ﬂaxseed and control groups at different ages. Normal ovaries of 2.5 (n = 19),
3 (n = 11) and 3.5 (n = 16) year old hens fed a ﬂaxseed enriched diet had signiﬁcantly lower expression of COX-2 protein (A&C) and mRNA (C) compared to normal ovaries
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625E. Eilati et al. / Gynecologic Oncology 130 (2013) 620–628present with cancer. Therefore long-term intervention with ﬂaxseed
was effective in chemo-prevention as well as suppression, whereas
one-yearwas not an adequate length of time on diet to achieve effective
prevention. These results were in agreement with a study that showed
ﬂaxseed reduced the incidence, number and growth of tumors in
a carcinogen-induced breast cancer model in rats [19,20]. Moreover,
a randomized, placebo controlled, clinical trial in postmenopausal
women with newly diagnosed breast cancer also found that the daily
consumption, from the time of diagnosis to surgery, of 25 g ﬂaxseed
in a mufﬁn formulation, reduced tumor cell proliferation and increased
apoptosis, whereas placebo mufﬁn did not [21]. This is the ﬁrst report
describing the long term therapeutic efﬁcacy of ﬂaxseed enriched diet
on the prevention of ovarian cancer in the laying hen. Our ﬁnding
has a therapeutic potential because women at high risk for developing
ovarian cancer could supplement their diet with ﬂaxseed which may
prevent ovarian cancer or signiﬁcantly delay its progression.
We and others have shown that COX-1 is over-expressed in ovarian
cancer [2–4]. The regulation of PGE2 synthesis by COX-1 in ovarian can-
cer cell lines [22] and hen ovaries with tumor [4] has been previously
shown. These ﬁndings indicate that targeting COX-1 activity may be
a mechanism of ﬂaxseed action to attenuate and even suppress the
ovarian cancer. We found no changes in COX-1 protein and mRNA
expression in the normal or cancerous ovaries of laying hens on ﬂax-
seed diet compared to the hens on control diet indicating that ﬂaxseed
does not affect the expression of COX-1 enzyme in hen ovaries. How-
ever, it is likely that the omega-3 fatty acids in ﬂaxseed decrease
COX-1 enzyme activity by modulating substrate levels, as described
below, resulting in a decrease in PGE2.
Many years of ovulation, longer exposure to environmental factors,
ovarian aging and accumulated DNA damagemight be associatedwith
increased rate of ovarian cancer with age. We have shown an increase
in the ovarian cancer incidence in the laying hen after two years of
ovulation, concomitant with increased PGE2 levels [16]. Moreover,
we have shown that while COX-1 increases with cancer, COX-2 in-
creases with age [3]. We propose that the age-related increase in
PGE2 may help to establish a pro-carcinogenic environment which
helps to promote ovarian carcinogenesis.
Elevation of PGE2 in ovarian cancer has beenpreviously reported [23].
Prostaglandins are potentmediators of intercellular communication, andhigh concentrations of PGE2 are believed to be immunosuppressive of T
cell-mediated immunity [24], increase angiogenesis [25] and stimulate
cell proliferation and inhibit apoptosis in ovarian cancer cell lines [26].
Consumption of the ﬂaxseed-enriched diet decreased the concentration
of PGE2 in both normal and cancerous ovaries of the hens, regardless of
their age. Flaxseed has been reported to reduce PGE2 levels in kidney
tissue in rats [27], injured skin in mice [28] and skeletal muscle in chicks
[29]. Moreover, Urick et al. showed that treatment of the henswith a diet
containing 0.1% aspirin for one year reduced PGE2 concentrations in the
liver and decreased the stage but not the incidence of ovarian cancer
[30]. The mechanisms by which the OM-3FAs inhibit PGE2 remain to
be fully elucidated. Dietary OM-3FAs may modulate substrate pools
available to COXs and lipoxygenases (LOX), thereby controlling the
downstream eicosanoid formation and subsequent receptor activation
[31]. The OM-6FA arachidonic acid (AA) is the predominant substrate
for both COX enzymes. The omega-3 fatty acid EPA can compete with
AA and act as an alternative substrate for COX enzymes [32]. COX en-
zymes convert OM6-FAs to 2-series PG products such as PGE2 whereas
the end products of COX enzymes activity on OM-3FAs are 3-series
prostaglandins such as PGE3. The 3-series PG products are generally
less pro-inﬂammatory than the 2-series products [33–35]. Although a
reduction in tissue levels of pro-tumorigenic PGE2 alone could explain
the anti-cancer properties of EPA, it is possible that PGE3 per se could
also contribute to the anti-tumorigenic activity of EPA [36].
COX-2 initiates the inﬂammatory process [37] and is related to
the formation and promotion of tumors and inhibition of apoptosis,
angiogenesis and the metastatic process [38]. Consumption of
OM3-FAs enriched diets had inhibitory effects on COX-2 and prosta-
glandin production in both plasma and experimentally induced
tumors [39] but the effect of ﬂaxseed, as a plant source of OM-3FAs
on COX-2 expression in ovarian cancer is unknown. Our data indicat-
ed that ﬂaxseed enriched diet decreases the COX-2 expression in
normal ovaries of hens aged 2.5, 3 and 3.5 years compared to age
matched hens fed control diet. Furthermore, ﬂaxseed diet decreased
the COX-2 expression in cancerous ovaries of hens aged 3 and
3.5 years compared to cancerous ovaries of age-matched hens fed
control diet. Our results are in agreement with previous reports
that have shown the dietary ﬂaxseed reduces COX-2 expression
in colon cancer in rats [40] and the dietary ALA reduces COX-2
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Fig. 5. COX-2 protein and mRNA expression in cancerous ovaries of hens fed ﬂaxseed enriched diet versus cancerous ovaries of hens fed control diet. The 3 (n = 9) and 3.5 (n = 4)
year old hens fed a ﬂaxseed enriched diet had lower COX-2 protein (A&B) andmRNA (C) expression than 3 (n = 13) and 3.5 (n = 10) year old hens with ovarian cancer fed control
diet, respectively; *, P b 0.05; Bars indicate standard error.
626 E. Eilati et al. / Gynecologic Oncology 130 (2013) 620–628expression and induces apoptosis in hepatoma cells [41]. The pres-
ent study conﬁrms previous reports and demonstrates that COX-2
increases as a function of age, not ovarian cancer per se.
Taken together, our ﬁndings demonstrated that the long-term
dietary intervention with ﬂaxseed decreased the concentration of
PGE2; the expression of COX-2 in ovaries and incidence and severity
of ovarian cancer in the laying hens. Regardless if the ovarian can-
cers originate from the ovarian surface epithelium, or result from
carcinogenic transformation of the distal tubal epithelium, the
inﬂammation associated with ovulation likely contributes to the
development of cancers from both sites. Flaxseed reduces PGE2, the
most pro-inﬂammatory prostaglandin thus reduces the inﬂammationassociated with ovulation. These ﬁndings are in consistent with the
notion that high concentrations of PGE2 contributes to initiation
and/or progression of ovarian cancer and reducing PGE2 concentra-
tions in the ovary may prevent this highly lethal malignancy.
Moreover, we demonstrated that the decreased COX-2 expression
corresponds to the reduction in PGE2 concentrations suggesting
that blocking its expression might be a suitable target to reduce
ovarian cancer. To our knowledge the present study provides the
ﬁrst insight into the efﬁcacy of long-term consumption of ﬂaxseed-
enriched diet on incidence and severity of ovarian cancer, COX
enzymes expression and prostaglandin E2 concentration in ovarian
tissue. These ﬁndings may provide the basis for clinical trials of
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Fig. 6. Comparison of prostaglandin E2 concentrations in ovaries of hens fed a ﬂaxseed
enriched diet and hens fed control diet. (A) There was a signiﬁcant reduction in con-
centration of PGE2 in normal ovaries of hens fed a ﬂaxseed enriched diet compared
to normal ovaries of hens fed control diet regardless of age. (B) PGE2 concentration
in cancerous ovaries of 3 (n = 8) and 3.5 (n = 4) year old hens fed a ﬂaxseed enriched
diet was signiﬁcantly lower than PGE2 concentration in cancerous ovaries 3 (n = 8)
and 3.5 (n = 8) year old hens fed control diet. *, P b 0.05; **, P b 0.01; ***, P b 0.001;
Bars indicate standard error.
627E. Eilati et al. / Gynecologic Oncology 130 (2013) 620–628dietary intervention targeting prostaglandin biosynthesis for the
prevention and treatment of ovarian cancer.
Conﬂict of interest statement
The authors declare that there are no conﬂicts of interest.
Acknowledgments
This work was funded by NIH (1R01 AT005295), National Center
for Complementary and Alternative Medicine Grant AT004085 (DBH)
and American Institute for Cancer Research Grant 06-A043 (DBH). We
are grateful for the lab management by Carrie Small and poultry farm
management by Chet Utterback, DouglasHilgendorf and PamUtterback.
We also thank Dr. Karen Hales for her suggestions and review of this
manuscript.
References
[1] Gupta RA, Tejada LV, Tong BJ, Das SK, Morrow JD, Dey SK, et al. Cyclooxygenase-1
is overexpressed and promotes angiogenic growth factor production in ovarian
cancer. Cancer Res 2003;63:906–11.
[2] Daikoku T, Wang D, Tranguch S, Morrow JD, Orsulic S, DuBois RN, et al. Cycloox-
ygenase-1 is a potential target for prevention and treatment of ovarian epithelial
cancer. Cancer Res 2005;65:3735–44.
[3] Hales DB, Zhuge Y, Lagman JA, Ansenberger K, Mahon C, Barua A, et al.
Cyclooxygenases expression and distribution in the normal ovary and their role
in ovarian cancer in the domestic hen (Gallus domesticus). Endocrine 2008;33:
235–44.
[4] Urick ME, Johnson PA. Cyclooxygenase 1 and 2 mRNA and protein expression in
the Gallus domesticus model of ovarian cancer. Gynecol Oncol 2006;103:673–8.
[5] Greene ER, Huang S, Serhan CN, Panigrahy D. Regulation of inﬂammation in can-
cer by eicosanoids. Prostaglandins Other Lipid Mediat 2011;96:27–36.
[6] Budwig J. Cytostatic or cytodynamic control of cancer? Hippokrates 1956;27:
605–12.[7] Lin X, Gingrich JR, BaoW, Li J, Haroon ZA, Demark-WahnefriedW. Effect of ﬂaxseed
supplementation on prostatic carcinoma in transgenic mice. Urology 2002;60:
919–24.
[8] Bommareddy A, Zhang X, Schrader D, Kaushik RS, Zeman D, Matthees DP, et al.
Effects of dietary ﬂaxseed on intestinal tumorigenesis in Apc(Min) mouse. Nutr
Cancer 2009;61:276–83.
[9] Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3
fatty acids for the prevention of cancer: a review of potential mechanisms. Am J
Clin Nutr 2004;79:935–45.
[10] Wang LQ. Mammalian phytoestrogens: enterodiol and enterolactone. J Chromatogr
B Analyt Technol Biomed Life Sci 2002;777:289–309.
[11] Fathalla MF. Incessant ovulation–a factor in ovarian neoplasia? Lancet 1971;2:163.
[12] Landen Jr CN, Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial
ovarian cancer. J Clin Oncol 2008;26(6):995–1005.
[13] Barua A, Bitterman P, Abramowicz JS, Dirks AL, Bahr JM, Hales DB, et al. Histopa-
thology of ovarian tumors in laying hens: a preclinical model of human ovarian
cancer. Int J Gynecol Cancer 2009;19:531–9.
[14] Ansenberger K, Zhuge Y, Lagman JA, Richards C, Barua A, Bahr JM, et al. E-cadherin
expression in ovarian cancer in the laying hen, Gallus domesticus, compared to
human ovarian cancer. Gynecol Oncol 2009;113:362–9.
[15] Ansenberger K, Richards C, Zhuge Y, Barua A, Bahr JM, Luborsky JL, et al. Decreased
severity of ovarian cancer and increased survival in hens fed a ﬂaxseed-enriched
diet for 1 year. Gynecol Oncol 2010;117:341–7.
[16] Eilati E, Pan L, Bahr JM, Hales DB. Age dependent increase in prostaglandin path-
way coincides with onset of ovarian cancer in laying hens. Prostaglandins Leukot
Essent Fatty Acids 2012;87:177–84.
[17] Zhuge Y, Lagman JA, Ansenberger K, Mahon CJ, Daikoku T, Dey SK, et al. CYP1B1
expression in ovarian cancer in the laying hen Gallus domesticus. Gynecol Oncol
2009;112:171–8.
[18] Skeehan DC, Hrapchak BB. Theory and practice of histotechnology. St. Louis:
Mosby; 1973 111–2.
[19] Thompson LU, Rickard SE, Orcheson LJ, Seidl MM. Flaxseed and its lignan and oil
components reduce mammary tumor growth at a late stage of carcinogenesis.
Carcinogenesis 1996;17:1373–6.
[20] Serraino M, Thompson LU. The effect of ﬂaxseed supplementation on the initia-
tion and promotional stages of mammary tumorigenesis. Nutr Cancer 1992;17:
153–9.
[21] Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Dietary ﬂaxseed alters
tumor biological markers in postmenopausal breast cancer. Clin Cancer Res
2005;11:3828–35.
[22] Kino Y, Kojima F, Kiguchi K, Igarashi R, Ishizuka B, Kawai S. Prostaglandin E2
production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not
cyclooxygenase-2. Prostaglandins Leukot Essent Fatty Acids 2005;73:103–11.
[23] Kushlinskii NE, Podistov Iu I, Laktionov KP, Karseladze AI, Babkina IV, Kerimova
GI. Prostaglandins E in the primary tumor, metastases, and ascitic ﬂuid of patients
with ovarian cancer. Biull Eksp Biol Med 1997;123:83–6.
[24] Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 fatty acid dietary recom-
mendations and food sources to achieve essentiality and cardiovascular beneﬁts.
Am J Clin Nutr 2006;83:1526S–35S.
[25] Rodriguez-Leyva D, Dupasquier CM, McCullough R, Pierce GN. The cardiovascular
effects of ﬂaxseed and its omega-3 fatty acid, alpha-linolenic acid. Can J Cardiol
2010;26:489–96.
[26] Munkarah AR, Morris R, Baumann P, Deppe G, Malone J, DiamondMP, et al. Effects
of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer
cells. J Soc Gynecol Investig 2002;9:168–73.
[27] Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA, Aukema HM. Effects of
ﬂaxseed derivatives in experimental polycystic kidney disease vary with animal
gender. Lipids 2006;41:1141–9.
[28] Takemura N, Takahashi K, Tanaka H, Ihara Y, Ikemoto A, Fujii Y, et al. Dietary, but
not topical, alpha-linolenic acid suppresses UVB-induced skin injury in hairless
mice when compared with linoleic acids. Photochem Photobiol 2002;76:657–63.
[29] Olomu JM, Baracos VE. Prostaglandin synthesis and fatty acid composition of
phospholipids and triglycerides in skeletal muscle of chicks fed combinations of
ﬂaxseed oil and animal tallow. Lipids 1991;26:743–9.
[30] Urick ME, Giles JR, Johnson PA. Dietary aspirin decreases the stage of ovarian can-
cer in the hen. Gynecol Oncol 2009;112:166–70.
[31] Moonen HJ, Dommels YE, van Zwam M, van Herwijnen MH, Kleinjans JC, Alink
GM, et al. Effects of polyunsaturated fatty acids on prostaglandin synthesis and
cyclooxygenase-mediated DNA adduct formation by heterocyclic aromatic amines
in human adenocarcinoma colon cells. Mol Carcinog 2004;40:180–8.
[32] SmithWL. Cyclooxygenases, peroxide tone and the allure of ﬁsh oil. Curr Opin Cell
Biol 2005;17:174–82.
[33] Kobel M, Reuss A, Bois A, Kommoss S, Kommoss F, Gao D, et al. The biological and
clinical value of p53 expression in pelvic high-grade serous carcinomas. J Pathol
2010;222:191–8.
[34] WadaM, DeLongCJ, HongYH, Rieke CJ, Song I, Sidhu RS, et al. Enzymes and receptors
of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic
acid-derived substrates and products. J Biol Chem 2007;282:22254–66.
[35] Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prosta-
glandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2
expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003;100:1751–6.
[36] Hawcroft G, Loadman PM, Belluzzi A, Hull MA. Effect of eicosapentaenoic acid on
E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal
cancer cells. Neoplasia 2010;12:618–27.
[37] Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes. J Clin
Invest 2001;107:1491–5.
628 E. Eilati et al. / Gynecologic Oncology 130 (2013) 620–628[38] Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, et al. Cyclo-
oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol
2001;2:544–51.
[39] Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, Spencer D, et al. The effect of
omega-3 FAs on tumour angiogenesis and their therapeutic potential. Eur J Cancer
2009;45:2077–86.[40] Bommareddy A, Arasada BL, Mathees DP, Dwivedi C. Chemopreventive ef-
fects of dietary ﬂaxseed on colon tumor development. Nutr Cancer 2006;54:
216–22.
[41] Vecchini A, Ceccarelli V, Susta F, Caligiana P, Orvietani P, Binaglia L, et al. Dietary
alpha-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma
cells. J Lipid Res 2004;45:308–16.
